Clearfield (CLFD) director awarded 2,544 restricted shares vesting by 2027

Rhea-AI Filing Summary

Sarcevic Ademir reported acquisition or exercise transactions in this Form 4 filing.

Clearfield, Inc. director Ademir Sarcevic received a grant of 2,544 shares of common stock with a stated price of $0.0000 per share. Following this award, his directly owned holdings increased to 5,317 shares. Restrictions on this restricted stock lapse on the first business day prior to the 2027 Annual Meeting of Shareholders.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sarcevic Ademir

(Last) (First) (Middle)

7050 WINNETKA AVE N., STE. 100

(Street)

BROOKLYN PARK MN 55428

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Clearfield, Inc. [ CLFD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/27/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock(1)	02/27/2026		A		2,544	A	$0	5,317	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Restrictions on Restricted Stock lapse the first business day prior to the 2027 Annual Meeting of Shareholders.

	Darrell Hammond by Power of Attorney for Ademir Sarcevic	03/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Clearfield (CLFD) director Ademir Sarcevic report in this Form 4?

Director Ademir Sarcevic reported receiving a grant of 2,544 shares of Clearfield common stock. The filing shows this as a grant or award acquisition at a stated price of $0.0000 per share, increasing his direct ownership to 5,317 shares.

How many Clearfield (CLFD) shares did the director acquire and at what price?

Ademir Sarcevic acquired 2,544 shares of Clearfield common stock at a stated transaction price of $0.0000 per share. This was reported as a grant, award, or other acquisition rather than an open-market purchase, increasing his direct holdings to 5,317 shares.

What type of equity award did Clearfield (CLFD) grant to its director?

Clearfield granted director Ademir Sarcevic restricted stock classified as common stock. The transaction code "A" identifies it as a grant, award, or other acquisition, covering 2,544 shares with restrictions that lapse before the 2027 Annual Meeting of Shareholders.

When do the restrictions on Ademir Sarcevic’s Clearfield (CLFD) restricted stock lapse?

Restrictions on the restricted stock granted to Ademir Sarcevic lapse on the first business day prior to the 2027 Annual Meeting of Shareholders. Until then, the shares are subject to restrictions noted in the footnote to the Form 4 filing.

What is Ademir Sarcevic’s Clearfield (CLFD) share ownership after this Form 4 transaction?

After receiving the restricted stock grant, Ademir Sarcevic directly owns 5,317 shares of Clearfield common stock. This total reflects the addition of 2,544 awarded shares as reported in the Form 4 transaction summary for non-derivative securities.

Does the Form 4 indicate a buy or sell of Clearfield (CLFD) shares by the director?

The Form 4 indicates an acquisition via grant, not an open-market buy or sell. The transaction code "A" and description show a grant, award, or other acquisition of 2,544 restricted shares, with no reported sales or dispositions in this filing.